BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 15564225)

  • 1. "If we can just 'stall' new unfriendly legislations, the scoreboard is already in our favour": transnational tobacco companies and ingredients disclosure in Thailand.
    MacKenzie R; Collin J; Sriwongcharoen K; Muggli ME
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii79-87. PubMed ID: 15564225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competing with kreteks: transnational tobacco companies, globalisation, and Indonesia.
    Lawrence S; Collin J
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii96-103. PubMed ID: 15564227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia.
    Tong EK; Glantz SA
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii118-24. PubMed ID: 15564214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Political economy of tobacco control in Thailand.
    Chantornvong S; McCargo D
    Tob Control; 2001 Mar; 10(1):48-54. PubMed ID: 11226361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to combat efforts to overturn bans on electronic nicotine delivery systems: lessons from tobacco industry efforts during the 1980s to open closed cigarette markets in Thailand.
    Patanavanich R; Glantz SA
    BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33500264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Preparing ourselves to become an international organization': Thailand Tobacco Monopoly's regional and global strategies.
    MacKenzie R; Ross H; Lee K
    Glob Public Health; 2017 Mar; 12(3):351-366. PubMed ID: 28139965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "A phony way to show sincerity, as we all well know": tobacco industry lobbying against tobacco control in Hong Kong.
    Knight J; Chapman S
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii13-21. PubMed ID: 15564215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobacco industry interference with tobacco control policies in Poland: legal aspects and industry practices.
    Balwicki Ł; Stokłosa M; Balwicka-Szczyrba M; Tomczak W
    Tob Control; 2016 Sep; 25(5):521-6. PubMed ID: 26418616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From transit hub to major supplier of illicit cigarettes to Argentina and Brazil: the changing role of domestic production and transnational tobacco companies in Paraguay between 1960 and 2003.
    Iglesias RM; Gomis B; Carrillo Botero N; Shepherd P; Lee K
    Global Health; 2018 Nov; 14(1):111. PubMed ID: 30454015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "A good personal scientific relationship": Philip Morris scientists and the Chulabhorn Research Institute, Bangkok.
    Mackenzie R; Collin J
    PLoS Med; 2008 Dec; 5(12):1737-48. PubMed ID: 19108600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Success counteracting tobacco company interference in Thailand: an example of FCTC implementation for low- and middle-income countries.
    Charoenca N; Mock J; Kungskulniti N; Preechawong S; Kojetin N; Hamann SL
    Int J Environ Res Public Health; 2012 Apr; 9(4):1111-34. PubMed ID: 22690186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "The world's most hostile environment": how the tobacco industry circumvented Singapore's advertising ban.
    Assunta M; Chapman S
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii51-7. PubMed ID: 15564221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cigarette company trade secrets are not secret: an analysis of reverse engineering reports in internal tobacco industry documents released as a result of litigation.
    Velicer C; Lempert LK; Glantz S
    Tob Control; 2015 Sep; 24(5):469-80. PubMed ID: 24920577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protecting the autonomy of states to enact tobacco control measures under trade and investment agreements.
    Mitchell A; Sheargold E
    Tob Control; 2015 Jun; 24(e2):e147-53. PubMed ID: 25361743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco control in Namibia: the importance of government capacity, media coverage and industry interference.
    Tam J; van Walbeek C
    Tob Control; 2014 Nov; 23(6):518-23. PubMed ID: 23788605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memoranda of understanding: a tobacco industry strategy to undermine illicit tobacco trade policies.
    Crosbie E; Bialous S; Glantz SA
    Tob Control; 2019 Dec; 28(e2):e110-e118. PubMed ID: 30659106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of graphic health warning labels on tobacco products in India: the interplay between the cigarette and the bidi industries.
    Sankaran S; Hiilamo H; Glantz SA
    Tob Control; 2015 Nov; 24(6):547-55. PubMed ID: 24950697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco industry successfully prevented tobacco control legislation in Argentina.
    Sebrié EM; Barnoya J; Pérez-Stable EJ; Glantz SA
    Tob Control; 2005 Oct; 14(5):e2. PubMed ID: 16183967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the European Union's illicit trade agreements with the four major Transnational Tobacco Companies.
    Joossens L; Gilmore AB; Stoklosa M; Ross H
    Tob Control; 2016 May; 25(3):254-60. PubMed ID: 26022741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobacco company efforts to influence the Food and Drug Administration-commissioned Institute of Medicine report clearing the smoke: an analysis of documents released through litigation.
    Tan CE; Kyriss T; Glantz SA
    PLoS Med; 2013; 10(5):e1001450. PubMed ID: 23723740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.